Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Gandrup – page 2

40 clinical trials in Gandrup, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Gandrup at a glance
40
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

40 trials in Gandrup

Open in trial search

Arteriosclerosis

Not yet recruiting

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Arteriosclerosis

Not yet recruiting

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Osteoarthritis

Not yet recruiting

Study on the Effects of PPV-06 and Paracetamol for Patients with Inflammatory Knee Osteoarthritis

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:HIS203-CRM197
  • Sponsor:Peptinov

Osteoarthritis

Not yet recruiting

A Study Testing How Well LTG-001 Works and Its Safety in Patients with Knee Osteoarthritis

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:LTG-001
  • Sponsor:Latigo Biotherapeutics Inc.

Type IIa hyperlipidaemia

Not yet recruiting

Study on MK-0616 for Reducing Heart Disease Events in Patients with Atherosclerotic Cardiovascular Disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:MK-0616
  • Sponsor:Merck Sharp & Dohme LLC

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Osteoarthritis

Not recruiting

Study on the Effects of LNA043 for Patients with Knee Osteoarthritis

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:LNA043
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Arthralgia

Not recruiting

Study on the Effects and Safety of ODM-111 and Paracetamol for Chronic Knee Pain in Osteoarthritis Patients

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:ODM-111
  • Sponsor:Orion Corporation

Acne

Not recruiting

Study of Topical Donepezil Hydrochloride Cream for Safety and Effectiveness in Adult Patients with Acne Vulgaris

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Donepezil Hydrochloride
  • Sponsor:Arctic Therapeutics ehf.

Obesity+1

Not recruiting

Study on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Gandrup

What the registry says about research in the country

01 Musculoskeletal Disorders

Extensive research focusing on knee osteoarthritis treatments, including innovative pain management solutions and cartilage regeneration therapies. Multiple trials are evaluating new medications and therapeutic approaches.

  • Knee Pain Management
  • Cartilage Regeneration
  • Joint Function Improvement

Studies include novel treatments like diclofenac gel and experimental compounds for pain relief and joint health.

02 Metabolic Conditions

Innovative trials addressing obesity and type 2 diabetes, with a focus on weight management therapies combined with lifestyle modifications.

  • Weight Management
  • Diabetes Control
  • Metabolic Health

Research includes dual-approach treatments targeting both weight loss and diabetic control in patients with combined conditions.

03 Cardiovascular Research

Groundbreaking studies in atherosclerotic cardiovascular disease prevention and treatment, focusing on reducing major adverse cardiovascular events.

  • Heart Disease Prevention
  • Cardiovascular Risk Management
  • Lipid Disorders

Clinical trials are evaluating new medications for preventing cardiac events in high-risk populations.

04 Neurological Conditions

Important research into Alzheimer's disease and migraine treatments, including pediatric studies for headache prevention.

  • Early Alzheimer's Intervention
  • Migraine Prevention
  • Pediatric Neurology

Trials include innovative treatments for early-stage Alzheimer's and specialized migraine therapies for young patients.

Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.